Search for other papers by Hui Li in
Google Scholar
PubMed
Search for other papers by Peng Wu in
Google Scholar
PubMed
developing personalized treatment strategies tailored to individual tumor profiles. CRISPR/Cas9-based epigenome editing The CRISPR/Cas9 technology has enabled targeted studies of gene function in thyroid cancer ( 88 , 89 ). Researchers have used this
Search for other papers by Dirk-Jan van Beek in
Google Scholar
PubMed
Search for other papers by Rachel S van Leeuwaarde in
Google Scholar
PubMed
Search for other papers by Carolina R C Pieterman in
Google Scholar
PubMed
Search for other papers by Menno R Vriens in
Google Scholar
PubMed
Parelsnoer Institute, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
Search for other papers by the DutchMEN Study Group in
Google Scholar
PubMed
. Considering the complexity of MEN1, a longitudinal database with a disease-specific framework was a necessity. Whereas strategies for conducting randomized controlled trials on rare diseases have been described, research methods for observational studies are
Search for other papers by Monia Cito in
Google Scholar
PubMed
Search for other papers by Silvia Pellegrini in
Google Scholar
PubMed
Vita-Salute San Raffaele University, Milan, Italy
Search for other papers by Lorenzo Piemonti in
Google Scholar
PubMed
Search for other papers by Valeria Sordi in
Google Scholar
PubMed
variability of isolated human islets and the need for lifelong immunosuppression. Different approaches using stem cells to support islet survival and function are being explored in preclinical and clinical settings ( 5 ). Now, the most advanced strategies to
Search for other papers by Wenrui Wang in
Google Scholar
PubMed
Search for other papers by Chuan Zhang in
Google Scholar
PubMed
metabolic, oxidative, and endoplasmic reticulum stresses; and on epigenetic changes due to chronic stress. We also review current antidiabetic strategies and potential future research directions that may identify a time window for alleviating the β
Search for other papers by E T Aristizabal Prada in
Google Scholar
PubMed
Search for other papers by C J Auernhammer in
Google Scholar
PubMed
preclinical data into clinical treatments strategies in NETs of the GEP system. Declaration of interest C J A has received research contracts (Ipsen, Novartis), lecture honorarium (Ipsen, Novartis, Pfizer, Amgen, Roche, Falk) and advisory board
Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital/ University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by S C Clement in
Google Scholar
PubMed
Search for other papers by W E Visser in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by C A Lebbink in
Google Scholar
PubMed
Search for other papers by D Albano in
Google Scholar
PubMed
Search for other papers by H L Claahsen-van der Grinten in
Google Scholar
PubMed
Search for other papers by A Czarniecka in
Google Scholar
PubMed
Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Search for other papers by R P Dias in
Google Scholar
PubMed
Search for other papers by M P Dierselhuis in
Google Scholar
PubMed
Search for other papers by I Dzivite-Krisane in
Google Scholar
PubMed
Search for other papers by R Elisei in
Google Scholar
PubMed
Search for other papers by A Garcia-Burillo in
Google Scholar
PubMed
Search for other papers by L Izatt in
Google Scholar
PubMed
Search for other papers by C Kanaka-Gantenbein in
Google Scholar
PubMed
Search for other papers by H Krude in
Google Scholar
PubMed
Search for other papers by L Lamartina in
Google Scholar
PubMed
Search for other papers by K Lorenz in
Google Scholar
PubMed
Search for other papers by M Luster in
Google Scholar
PubMed
Search for other papers by R Navardauskaitė in
Google Scholar
PubMed
Search for other papers by M Negre Busó in
Google Scholar
PubMed
Search for other papers by K Newbold in
Google Scholar
PubMed
Search for other papers by R P Peeters in
Google Scholar
PubMed
Search for other papers by G Pellegriti in
Google Scholar
PubMed
Search for other papers by A Piccardo in
Google Scholar
PubMed
Search for other papers by A L Priego in
Google Scholar
PubMed
Search for other papers by A Redlich in
Google Scholar
PubMed
Search for other papers by L de Sanctis in
Google Scholar
PubMed
Search for other papers by M Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by A S P van Trotsenburg in
Google Scholar
PubMed
Search for other papers by F A Verburg in
Google Scholar
PubMed
Search for other papers by M Vriens in
Google Scholar
PubMed
Search for other papers by T P Links in
Google Scholar
PubMed
Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK
Office for Rare Conditions, University of Glasgow, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by H M van Santen in
Google Scholar
PubMed
primary malignancies ( 16 , 17 , 18 ). With current treatment strategies, the overall survival in pediatric patients with DTC is excellent. This excellent survival raises the question whether treatment may be given less ‘aggressively’ aiming to reduce
Search for other papers by Michael C Velarde in
Google Scholar
PubMed
Search for other papers by Mikaela Erlinda M Bucu in
Google Scholar
PubMed
Search for other papers by Maria Antonia E Habana in
Google Scholar
PubMed
endometriosis and funding support for endometriosis research in the region are still very limited. Clinical presentation and severity of endometriosis in Asian women Women with endometriosis often present with dysmenorrhea, severe chronic pelvic pain
Search for other papers by Maximilian Bielohuby in
Google Scholar
PubMed
Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed
Search for other papers by Uwe Schwahn in
Google Scholar
PubMed
research purposes in laboratory rodents. The replacement of radioactivity by an enzymatic label in 1971 by Engvall and Perlmann (ELISA) ( 5 ) as well as by van Weemen and Schuurs (EIA) ( 6 ), and the associated increased handling convenience led to a boost
Laboratory for Anthropology and Skeletal Biology, Institute of Anatomy, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Search for other papers by Petar Milovanovic in
Google Scholar
PubMed
Search for other papers by Björn Busse in
Google Scholar
PubMed
development of preventive and therapeutic strategies to combat one of the most common health problems in aged individuals worldwide. Role of osteocytes in bone adaptation Currently, many bone properties are considered to be controlled or mediated by
Search for other papers by Kaili Yang in
Google Scholar
PubMed
Search for other papers by Jiarui Li in
Google Scholar
PubMed
Search for other papers by Yuejuan Cheng in
Google Scholar
PubMed
Search for other papers by Chunmei Bai in
Google Scholar
PubMed
unmet need for effective management strategies. Well-designed trials can improve the efficiency of clinical research, especially for uncommon malignancies like GEP-NENs. Efforts have been made to optimize the design of GEP-NEN trials in the past two